VIOFTAINS - sterile water-salt solutions of regulatory protein-peptide compounds, isolated from the intercellular space of the eye tissues of animals. They do not suppress the processes occurring in the body, but due to stimulation of the body's defenses and restoration of the mechanism of self-regulation has an effect on the root cause of the disease.
VIOFTANES are an effective means of preventing eye diseases such as cataracts, corneal and retinal degeneration, vitreous humors, myopia, farsightedness, macular degeneration, etc.
VIOPHTAN 02 (Biofluovitis of the lens of the eye)
Selection source: crystalline lens
Viofan 02 is recommended for use in cataracts, initial glaucoma, clouding of the lens in elderly people, dryness of the cornea.
Helps restore the transparency of the lens and inhibits the development of turbidity.
The lens of the eye along with the cornea and the vitreous body is part of the refracting (optical) system of the eyeball. It is a biconvex transparent lens having a diameter of 9 millimeters to 1 centimeter and a thickness of about 4 millimeters.
Cataract is a disease of the eye, the main sign of which is the cloudiness of the main substance or capsule of the lens (a decrease in their transparency), accompanied by a decrease in visual acuity. Over the years, the eye cataract progresses, which is accompanied by a marked decrease in visual acuity, a sense of "fog" and "swaddling" before the eyes. And if the treatment is not timely, cataracts can lead to blindness.
Cataract is one of the most common eye diseases. So, according to statistics, the frequency of age-related cataract is 33 per 1000 population, and this figure significantly increases with age and reaches in the 70-80 years 260 per 1000 in men and 460 in 1000 in women. After 80 years almost 100 percent of the population suffers from cataracts.
Viofan 02 is recommended for use as an effective preventive agent, as well as at the initial stages of cataract development. Has a regulatory effect on the formation of fibers from the cells of the epithelium, as well as the protective effect on the epithelial cells themselves. Helps restore the transparency of the lens due to its regulatory effect on all structures of the lens. It inhibits the development of lens opacity regardless of the etiology of cataracts. At the initial stages of pathology, the use of Biofant 02 balm can cause a complete dissolution of cataracts.
It is used together with Vioftans 07 and 09.
Instructions for use: Bury in the conjunctival eye bag 1-2 drop at least 3 times a day for 2 months (with an initial cataract) or at least 6 months (with mature cataracts). When glaucoma - up to 6-8 times a day for 14-30 days.
In complex programs with the use of several Vioftans, an interval between instillation of VIOFTANS is recommended for at least 5 minutes!
It is combined with the reception of other ophthalmic means (it is necessary to observe a time interval of at least 5 minutes between their reception).
It is recommended to be used as separate courses 2-3 times a year as a preventive measure.
Burying more than 2 drops does not make sense, since only 1 drop is placed in the conjunctival sac. Eye drops should have room temperature - too cold drops cause a spasm of the eyelids. It is necessary to ensure that the tip of the pipette does not touch the eyelashes of the diseased eye in order to avoid infection and contamination of the solution.
Storage conditions: Store at room temperature or in a refrigerator, avoid sunlight. Do not store in the sun! It is recommended not to touch during instillation to the eyes and tightly close the lid, in order to avoid getting into the solution of bacteria. In its open form it retains its properties during the shelf life (2 years).
VIOFTANES can be used to treat pets.
ATTENTION!!! VIOFTAINS are not effective in the application without clarifying the diagnosis, but they do not have any adverse effect on the organ of vision and the body as a whole.
Developer: LLC "Institute for Bioregulation Problems", Moscow.
Producer: INPROBIOTEH.
All products are certified.
